Cite
MLA Citation
Oliver Sartor et al.. “Radium‐223 Safety, Efficacy, and Concurrent Use with Abiraterone or Enzalutamide: First U.S. Experience from an Expanded Access Program.” Oncologist, vol. 23, 2018, pp. 193–202. http://access.bl.uk/ark:/81055/vdc_100057157314.0x000037